Furthermore, CLEC3B has been identified in various oncological pathologies, including breast, bladder, cervical, and ovarian cancers, melanoma, and gastric adenocarcinoma (Verspaget et al., 1994; Arvanitis et al., 2002; Brunner et al., 2007; Looi et al., 2009; Zhang et al., 2017). This evidence concerns the gene CLEC3B and ovarian cancer.